{"id":"W4416852000","doi":"10.1038/d43747-025-00111-4","title":"The year of the bispecific in oncology and beyond","year":2025,"lang":"en","type":"article","venue":"Biopharma Dealmakers","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Bispecific antibody; Quarter (Canadian coin); Antibody therapy; Radiation oncology; Momentum (technical analysis)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01282332,0.0009126694,0.0009577012,0.002098844,0.002271013,0.01027036,0.001301319,0.007644441,0.02081629],"category_scores_gemma":[0.01488295,0.0005356243,0.0008607891,0.001973602,0.006526719,0.007507447,0.003638237,0.01205082,0.005804329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007456944,"about_ca_system_score_gemma":0.007747757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006595665,"about_ca_topic_score_gemma":0.01237712,"domain_scores_codex":[0.9963283,0.0006456844,0.0001789555,0.0005206574,0.001641581,0.0006848848],"domain_scores_gemma":[0.989683,0.002500893,0.0005232372,0.0006068509,0.003422063,0.003263871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000219148,0.00008731332,0.0004395843,0.0002068908,0.00001596403,0.0002017881,0.0002652986,0.0001194383,0.0008679524,0.1247465,0.8064744,0.06635565],"study_design_scores_gemma":[0.000007598441,0.00003725965,0.0001628875,0.00008025282,0.000002994215,0.00006719637,0.0001214017,0.00003231234,0.0001808834,0.003525695,0.9957744,0.000007122938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.003716068,0.1652626,0.003651384,0.4133421,0.3289896,0.00004850599,0.0005314789,0.0001670718,0.08429118],"genre_scores_gemma":[0.07578703,0.1307992,0.00571978,0.2492634,0.1132271,0.0001195685,0.0006402267,0.0004514923,0.4239922],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02081629,"threshold_uncertainty_score":0.06963748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01538064952659011,"score_gpt":0.3433365801308608,"score_spread":0.3279559306042707,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}